Elevated serum protein oxidative stress in siblings of patients with schizophrenia

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 398-399

  Massuda, Raffael ^a   Pedrini, Mariana ^a   Reckziegel, Ramiro ^a   Costanzi, Monise ^a   Ferrari, Pamela ^a   Gubert, Carolina ^a   Gama, Clarissa S ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; BODY MASS; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CARBONYLATION; SCHIZOPHRENIA; SIBLING; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADULT; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SCHIZOPHRENIA; SIBLINGS; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84878965418     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.025     Document Type: Letter

References (10)

1. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., Cunha A.B., Cereser K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., Goncalves C.A. Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 2007, 41(6):523-529.
2. Arai M., Yuzawa H., Nohara I., Ohnishi T., Obata N., Iwayama Y., Haga S., Toyota T., Ujike H., Arai M., Ichikawa T., Nishida A., Tanaka Y., Furukawa A., Aikawa Y., Kuroda O., Niizato K., Izawa R., Nakamura K., Mori N., Matsuzawa D., Hashimoto K., Iyo M., Sora I., Matsushita M., Okazaki Y., Yoshikawa T., Miyata T., Itokawa M. Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch. Gen. Psychiatry 2010, 67(6):589-597.
3. Ben Othmen L., Mechri A., Fendri C., Bost M., Chazot G., Gaha L., Kerkeni A. Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings. Progress in neuro-psychopharmacology & biological psychiatry 2008, 32(1):155-159.
4. Brunelin J., d'Amato T., Van Os J., Costes N., Suaud Chagny M.F., Saoud M. Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress. Psychiatry research 2010, 181(2):130-135.
5. Dietrich-Muszalska A., Olas B., Glowacki R., Bald E. Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology 2009, 59(1):1-7.
6. Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr. Opin. Neurobiol. 2009, 19(2):220-230.
7. Gama C.S., Salvador M., Andreazza A.C., Kapczinski F., Silva Belmonte-de-Abreu P. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Progress in neuro-psychopharmacology & biological psychiatry 2006, 30(3):512-515.
8. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160(4):636-645.
9. Martinez-Cengotitabengoa M., Mac-Dowell K.S., Leza J.C., Mico J.A., Fernandez M., Echevarria E., Sanjuan J., Elorza J., Gonzalez-Pinto A. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr. Res. 2012, 137(1-3):66-72.
10. Pedrini M., Massuda R., Fries G.R., de Bittencourt Pasquali M.A., Schnorr C.E., Moreira J.C., Teixeira A.L., Lobato M.I., Walz J.C., Belmonte-de-Abreu P.S., Kauer-Sant'Anna M., Kapczinski F., Gama C.S. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J. Psychiatr. Res. 2012, 46(6):819-824.